End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
50.2 CNY | +1.93% | +1.56% | +15.16% |
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The group's high margin levels account for strong profits.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 64.63 times its estimated earnings per share for the ongoing year.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+15.16% | 1.82B | - | ||
-27.52% | 16.33B | A | ||
-40.04% | 2.96B | C+ | ||
-6.86% | 1.55B | - | ||
+38.67% | 1.41B | B+ | ||
-15.36% | 976M | - | ||
-26.08% | 846M | - | C- | |
+3.53% | 811M | - | ||
-24.63% | 631M | B+ | ||
+23.58% | 593M | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 300049 Stock
- Ratings Inner Mongolia Furui Medical Science Co., Ltd.